Buspirone modulates basal and fluoxetine-stimulated dialysate levels of
dopamine, noradrenaline and serotonin in the frontal cortex of freely moving
rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic
receptors underlie its actions
by
Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ
Institut de Recherches Servier,
Psychopharmacology Department,
Croissy-sur-Seine, Paris, France.
Neuroscience 1999; 93(4):1251-62
ABSTRACT
The serotonin1A receptor partial agonist, buspirone, also displays antagonist
properties at D2 receptors and is metabolized to the alpha2-adrenergic receptor
antagonist, 1-(2-pyrimidinyl-piperazine). Herein, we examined mechanisms
underlying the influence of buspirone alone, and in association with the
serotonin reuptake inhibitor, fluoxetine, upon extracellular levels of
serotonin, dopamine and noradrenaline simultaneously quantified in the frontal
cortex of freely moving rats. Buspirone (0.01-2.5 mg/kg, s.c.) dose-dependently
decreased dialysate levels of serotonin (-50%), and increased those of dopamine
(+100%) and noradrenaline (+140%). The reduction by buspirone of serotonin
levels was abolished by the serotonin1A receptor antagonist, WAY 100,635 (0.16),
which did not, however, modify its influence upon dopamine and noradrenaline. In
contrast to buspirone, the serotonin reuptake inhibitor, fluoxetine (10.0),
increased frontocortical levels of serotonin (+ 120%), dopamine (+55%) and
noradrenaline (+90%). Buspirone dose-dependently (0.01-2.5) decreased the
induction by fluoxetine of serotonin levels yet potentiated (three-fold) its
elevation of dopamine and noradrenaline levels. The serotonin1A agonist,
8-hydroxy-2-(di-n-propyl-amino)-tetralin (0.16), mimicked the action of
buspirone in reducing resting levels of serotonin (-60%) and in enhancing those
of dopamine (+135%) and noradrenaline (+165%). Like buspirone, it attenuated the
influence of fluoxetine upon serotonin levels, yet facilitated its influence
upon dopamine and noradrenaline levels. In contrast, WAY 100,635 selectively
potentiated the increase in levels of serotonin (two-fold) versus dopamine and
noradrenaline elicited by fluoxetine. Further, WAY 100,635 abolished the
inhibitory influence of buspirone upon fluoxetine-induced serotonin release, but
only partly interfered with its potentiation of fluoxetine-induced increases in
dopamine and noradrenaline levels. The D2/D3 receptor antagonist, raclopride
(0.16), increased basal dopamine (+60%) levels but little influenced those of
serotonin and noradrenaline, and failed to modify the action of fluoxetine. The
alpha2-adrenergic receptor antagonist, 1-(2-pyrimidinyl-piperazine) (2.5), which
did not modify resting levels of serotonin, markedly increased those of dopamine
(+90%) and noradrenaline (+190%) and potentiated (two-fold) the increases in
dialysate levels of dopamine, noradrenaline and serotonin provoked by
fluoxetine. Further, the alpha2-adrenergic receptor agonist, S18616, attenuated
the enhancement by buspirone of the fluoxetine-induced increase in levels of
dopamine and noradrenaline. In conclusion, the inhibitory influence of buspirone
upon resting and fluoxetine-stimulated serotonin levels reflects its agonist
properties at serotonin1A autoreceptors. The facilitatory influence of buspirone
upon resting and fluoxetine-stimulated dopamine and noradrenaline levels may
also involve its serotonin1A properties. However, its principal mechanism of
action in this respect is probably the alpha2-adrenergic antagonist properties
of its metabolite, 1-(2-pyrimidinyl-piperazine). The present observations are of
significance to experimental and clinical studies of the influence of buspirone
upon depressive states, alone and in association with antidepressant agents.
SSRIs
5-HT1a
Serotonin
Buspirone
Alprazolam
Alpha2 antagonists
Buspirone and 5-HT1a receptors
Buspirone (Buspar): prescribing information (PDF)
Refs
HOME
HedWeb
Future Opioids
BLTC Research
Paradise-Engineering
The Hedonistic Imperative
When Is It Best To Take Crack Cocaine?

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family